Explore peer-reviewed studies on antimicrobial resistance, sterilization protocols, and outbreak management
Exploring the balance between efficacy and safety in advanced lung cancer treatment, focusing on the risk of drug-induced interstitial lung disease from targeted therapies like osimertinib and savolitinib.